Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs
Authors:
- 1 July 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 57 (7) , 923-927
Abstract
Pantoprazole is an irreversible proton pump inhibitor that is administered as a racemic mixture clinically. The effects of pantoprazole sodium (PAN·Na) enantiomers on acid‐related lesions were compared using models of pylorus ligation induced ulcer, histamine induced ulcer and reflux oesophagitis in rats and guinea‐pigs. Compared with (+)‐PAN·Na and (±)‐PAN·Na, (‐)‐PAN·Na showed much stronger inhibitory effects on pylorus ligation induced and histamine induced ulcers, but similar effects on reflux oesophagitis. The doses of (‐)‐PAN·Na, (+)‐PAN·Na and (±)‐PAN·Na required for 50% inhibition (ID50) of acid‐related lesions were 1.28, 5.03 and 3.40 mg kg−1 against pylorus ligation induced ulcer, 1.20, 4.28 and 3.15 mg kg−1 against histamine induced ulcer, and 2.92, 3.56 and 3.70 mg kg−1 against reflux oesophagitis, respectively. The inhibitory effects of PAN·Na enantiomers on basal gastric acid output were compared in rats with acute fistula. In contrast to inhibitory rates of 89.3% and 83.6% on gastric acid output by (‐)‐PAN·Na and (±)‐PAN·Na at 1.5 mg kg−1, (+)‐PAN·Na had an inhibitory rate of only 24.7% at the same dose. The above results indicate that (‐)‐PAN·Na is more potent than (+)‐PAN·Na at inhibiting acid‐related lesions owing to its stronger inhibition of acid secretion.Keywords
This publication has 26 references indexed in Scilit:
- Comparison of the Effects of Pantoprazole Enantiomers on Gastric Mucosal Lesions and Gastric Epithelial Cells in RatsJournal of Health Science, 2004
- Eradication of Helicobacter pylori by 7‐Day Triple‐Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double‐Blind, Randomized StudiesHelicobacter, 2003
- PantoprazoleDrugs, 2003
- Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazoleAlimentary Pharmacology & Therapeutics, 2001
- Pharmacokinetic Studies with Esomeprazole, the (S)-Isomer of OmeprazoleClinical Pharmacokinetics, 2001
- Long‐term therapy with pantoprazole in patients with peptic ulceration resistant to extended high‐dose ranitidine treatment.Alimentary Pharmacology & Therapeutics, 1994
- Pantoprazole: a novel H+/K+-ATPase inhibitor with an improved pH stabilityEuropean Journal of Pharmacology, 1992
- Relations among autonomic nerve dysfunction, oesophageal motility, and gastric emptying in gastro-oesophageal reflux disease.Gut, 1991
- Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overviewClinical Pharmacology & Therapeutics, 1986
- Acute gastric ulceration in the guinea‐pig induced by a single intraperitoneal injection of aqueous histamineThe Journal of Pathology and Bacteriology, 1965